Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1549230 NEW YORK, NY

Position in CLDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,211,781
+$931,326 QoQ
Shares Held
140,064
+3.8% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#69
of 252 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CLDX Over Time

Shares Held

Position Value (USD)

Derivatives in CLDX

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$1,239,093
PutShares
33,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. CLDX ranks #30 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLDX

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,239,093 33,300
2026-06-30 $5,211,781 140,064
2026-03-31 $4,280,455 134,945
2026-03-31 $1,056,276 33,300
2024-12-31 $1,538,943 60,900
2024-09-30 $3,065,898 90,200
2024-09-30 $3,065,898 90,200
2023-09-30 $544,896 19,800
2023-03-31 $704,344 19,576
2023-03-31 $809,550 22,500
2022-12-31 $1,393,837 31,273
2022-09-30 $1,043,386 37,118
2022-06-30 $2,054,352 76,200
2022-06-30 $1,673,272 62,065
2022-06-30 $2,359,000 87,500
2022-03-31 $1,304,498 38,300
2022-03-31 $2,237,742 65,700
2022-03-31 $2,113,933 62,065
2021-12-31 $1,756,188 45,450
2021-12-31 $2,337,720 60,500
2021-12-31 $1,816,080 47,000
2021-09-30 $2,818,278 52,200
2021-09-30 $4,303,003 79,700
2021-09-30 $1,425,821 26,409
2021-06-30 $1,750,182 52,338
2021-06-30 $2,270,576 67,900
2021-03-31 $1,528,499 74,199
2020-12-31 $3,147,818 179,670
2020-09-30 $2,760,115 186,117
2020-06-30 $2,714,868 208,836